rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Valerie Malyvanh Jansen

Director

Company insider

Files Form 4 as: Director, OnKure Therapeutics; Chief Medical Officer, Elevation Oncology.

Every Form 4 they filed

In numbers

Trades disclosed
16
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
1
First trade
19 Oct 2021
Last trade
7 Aug 2026
Last filed
11 Aug 2026

Companies traded

Where they are an officer
Elevation OncologyOfficer · last 15 Feb 20250 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
OKUR OnKure TherapeuticsDirector · Biotechnology · last 7 Aug 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
7 Aug 2026filed 11 Aug 2026OKUR OnKure Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—22,350 at $0.00filing
7 Aug 2026filed 11 Aug 2026OKUR OnKure Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—22,350 at $0.00filing
4 Jun 2026filed 8 Jun 2026OKUR OnKure Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—7,650 at $0.00filing
4 Jun 2026filed 8 Jun 2026OKUR OnKure Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—7,650 at $0.00filing
28 May 2025filed 30 May 2025OKUR OnKure Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—7,650 at $0.00filing
15 Feb 2025filed 19 Feb 2025Elevation Oncologyoption or derivativeSEC FORM 4 Code A—275,000 at $0.00filing
15 Feb 2025filed 19 Feb 2025Elevation OncologySEC FORM 4 Code M—17,500filing
15 Feb 2025filed 19 Feb 2025Elevation OncologySEC FORM 4 Code F$3,4775,189 at $0.67filing
4 Oct 2024filed 8 Oct 2024OKUR OnKure Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—15,300 at $0.00filing
15 Feb 2024filed 19 Feb 2025Elevation Oncologyoption or derivativeSEC FORM 4 Code M—17,500 at $0.00filing
15 Feb 2024filed 20 Feb 2024Elevation Oncologyoption or derivativeSEC FORM 4 Code A—225,000 at $0.00filing
15 Feb 2024filed 20 Feb 2024Elevation Oncologyoption or derivativeSEC FORM 4 Code A—70,000 at $0.00filing
15 Feb 2023filed 17 Feb 2023Elevation Oncologyoption or derivativeSEC FORM 4 Code A—130,000 at $0.00filing
6 Jan 2023filed 10 Jan 2023Elevation Oncologyoption or derivativeSEC FORM 4 Code A—130,000 at $0.00filing
14 Feb 2022filed 16 Feb 2022Elevation Oncologyoption or derivativeSEC FORM 4 Code A—60,000 at $0.00filing
19 Oct 2021filed 21 Oct 2021Elevation Oncologyoption or derivativeSEC FORM 4 Code A—40,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Nobody else traded the same names lately.